278 related articles for article (PubMed ID: 36738953)
1. Pachymeningitis associated with IgG4-related disease and ANCA positivity: Case report and review of the literature.
Gautier F; Neumann L; Adle-Biassete H; Rubenstein E; Bernat AL; Chimon A; Mouly S; Sène D; Comarmond C
Autoimmun Rev; 2023 Apr; 22(4):103285. PubMed ID: 36738953
[TBL] [Abstract][Full Text] [Related]
2. IgG4-related hypertrophic pachymeningitis with ANCA-positivity: A case series report and literature review.
Xia C; Li P
Front Neurol; 2022; 13():986694. PubMed ID: 36188377
[TBL] [Abstract][Full Text] [Related]
3. [Clinical analysis of 15 cases with myeloperoxidase antineutrophil cytoplasmic antibody associated hypertrophic pachymeningitis].
Guan WJ; Ding YX; Liu LJ; Li W; Jing LJ; Zhang X; Zhang LJ; Li H; Cheng SH; Liu SY
Zhonghua Nei Ke Za Zhi; 2022 May; 61(5):565-569. PubMed ID: 35488609
[TBL] [Abstract][Full Text] [Related]
4. Do ANCA-associated vasculitides and IgG4-related disease really overlap or not?
Erden A; Bolek EC; Yardimci KG; Kilic L; Bilgen SA; Karadag O
Int J Rheum Dis; 2019 Oct; 22(10):1926-1932. PubMed ID: 31571413
[TBL] [Abstract][Full Text] [Related]
5. Hypertrophic pachymeningitis in ANCA-associated vasculitis: Clinical and immunopathological features and insights.
Shimojima Y; Sekijima Y
Autoimmun Rev; 2023 Jun; 22(6):103338. PubMed ID: 37062439
[TBL] [Abstract][Full Text] [Related]
6. Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody.
Yokoseki A; Saji E; Arakawa M; Kosaka T; Hokari M; Toyoshima Y; Okamoto K; Takeda S; Sanpei K; Kikuchi H; Hirohata S; Akazawa K; Kakita A; Takahashi H; Nishizawa M; Kawachi I
Brain; 2014 Feb; 137(Pt 2):520-36. PubMed ID: 24271323
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin-G4-related hypertrophic pachymeningitis with antineutrophil cytoplasmatic antibodies effectively treated with rituximab.
Popkirov S; Kowalski T; Schlegel U; Skodda S
J Clin Neurosci; 2015 Jun; 22(6):1038-40. PubMed ID: 25861887
[TBL] [Abstract][Full Text] [Related]
8. Hypertrophic pachymeningitis due to IgG4-related disease (RD-IgG4). A case report.
Sergio P; Alejandro R; Cristian F
Reumatol Clin (Engl Ed); 2023; 19(6):338-344. PubMed ID: 37179159
[TBL] [Abstract][Full Text] [Related]
9. [Orbital apex syndrome due to relapse during steroid tapering in a patient with MPO-ANCA-positive IgG4-related hypertrophic pachymeningitis].
Iwanami M; Ogawa T; Tanaka Y; Hyoudo A; Ueda Y; Miyamoto T
Rinsho Shinkeigaku; 2014; 54(1):52-5. PubMed ID: 24429649
[TBL] [Abstract][Full Text] [Related]
10. A Case of Hypertrophic Pachymeningitis Associated with Immunoglobulin-G4 and c-ANCA.
Wyrostek S; Chakrabarti S; Baldwin K; Avila JD
Case Rep Neurol; 2019; 11(3):290-294. PubMed ID: 31762760
[TBL] [Abstract][Full Text] [Related]
11. Hypertrophic pachymeningitis associated with antineutrophil cytoplasmic antibody-associated vasculitis: a case series of 15 patients.
Sakairi T; Sakurai N; Nakasatomi M; Ikeuchi H; Kaneko Y; Maeshima A; Nojima Y; Hiromura K
Scand J Rheumatol; 2019 May; 48(3):218-224. PubMed ID: 30394816
[TBL] [Abstract][Full Text] [Related]
12. Hypertrophic Pachymeningitis with Characteristics of Both IgG4-related Disorders and Granulomatosis with Polyangiitis.
Mori M; Sakai K; Saito K; Nojima T; Mohri M; Matsubara K; Hayashi S; Yamada M
Intern Med; 2022 Jun; 61(12):1903-1906. PubMed ID: 34803104
[TBL] [Abstract][Full Text] [Related]
13. [IgG4- and MPO-ANCA-associated hypertrophic pachymeningitis].
Aragonès JM; Arias-Rivero M; García-Barrionuevo JM; Lucchetti G
Rev Neurol; 2015 Nov; 61(10):454-7. PubMed ID: 26553176
[TBL] [Abstract][Full Text] [Related]
14. Hypertrophic pachymeningitis with MPO-ANCA-positive vasculitis.
Horino T; Takao T; Taniguchi Y; Terada Y
Clin Rheumatol; 2010 Jan; 29(1):111-3. PubMed ID: 19727912
[TBL] [Abstract][Full Text] [Related]
15. Hypertrophic Pachymeningitis Development in Eosinophilic Granulomatosis with Polyangiitis at Relapse of Disease: A Case-Based Review.
Kiyohara M; Shirai T; Nishiyama S; Sato H; Fujii H; Ishii T; Harigae H
Tohoku J Exp Med; 2022 Mar; 256(3):241-247. PubMed ID: 35321968
[TBL] [Abstract][Full Text] [Related]
16. Hypertrophic Pachymeningitis in Chinese Patients: Presentation, Radiological Findings, and Clinical Course.
Bi Z; Shang K; Cao J; Su Z; Bu B; Xu S; Liu C
Biomed Res Int; 2020; 2020():2926419. PubMed ID: 32879880
[TBL] [Abstract][Full Text] [Related]
17. IgG4-related pachymeningitis-Long term follow up and outcome of six patients.
Yardimci GK; Arslan D; Babaoğlu B; Bolek EC; Kilic L; Saglam A; Tuncer A; Söylemezoğlu F; Gocmen R; Oguz KK; Tan E; Karadag O
Int J Rheum Dis; 2023 Sep; 26(9):1853-1860. PubMed ID: 37403944
[TBL] [Abstract][Full Text] [Related]
18. Hypertrophic pachymeningitis in eosinophilic granulomatosis with polyangiitis.
Izuka S; Yamashita H; Takahashi Y; Kaneko H
Mod Rheumatol Case Rep; 2022 Jan; 6(1):80-82. PubMed ID: 34480185
[TBL] [Abstract][Full Text] [Related]
19. [Atypical headache and facial pain as a result of hypertrophic pachymeningitis in C-ANCA-positive Wegener's granulomatosis].
Kuhn J; Weber M; Hedde JP; Bewermeyer H
Med Klin (Munich); 2005 Apr; 100(4):209-12. PubMed ID: 15834530
[TBL] [Abstract][Full Text] [Related]
20. Coexistence of IgG4-related disease and ANCA-associated vasculitis: case report and review of the literature.
Korkmaz C; Yıldırım R; Dinler M; Cansu DU
Rheumatol Int; 2024 Mar; 44(3):557-572. PubMed ID: 37634133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
